logo
Cardiovascular safety of COX-2 inhibition
Spiriva® may slow decline in FEV1, a measure of lung function in patients with chronic obstructive pulmonary disease
Rimonabant shows positive results for weight loss and reduction of cardiovascular risk factors in overweight patients
Priority Paper Alerts
Pfizer suspend sales of painkilling drug, Bextra®
Biogen Idec psoriasis study reaches primary end point
Noven and Shire report positive preliminary results from ADHD treatment studies
Recently released preliminary results by Shire and Noven Pharmaceuticals of a methylphenidate transdermal system for the treatment of children with attention deficit hyperactivity disorder have shown promise in Phase II and III studies.
Proteins involved in the spread of cancer identified
Valganciclovir for cytomegalovirus prevention and treatment
Calcipotriol/betamethasone dipropionate
Update on sumatriptan
Management of community-acquired lower respiratory tract infections
Are the benefits of NSAIDs to decrease the risk of Alzheimer's disease a MIRAGE?
Lung cancer drug resistance and DNA damage signaling
Chronic tendon pain
Influence of serum epidermal growth factor on mechanical ventilation and survival in patients with acute respiratory distress syndrome
Does the addition of lamotrigine to risperidone improve psychotic symptoms and cognitive impairments in chronic schizophrenia?
Preparation of a polymeric reservoir naltrexone delivery device
PTH-related protein and Type 1 PTH receptor mRNA expression in ventricular myocardial hypertrophy
Therapy of chronic renal insufficiency
Interferon-α therapy and Type 1 diabetes mellitus in patients with hepatitis C
New advances in interleukin-1 blockade for the treatment of rheumatoid arthritis
Treatment options for carpal tunnel syndrome
Platelets and new antiplatelet drugs
Corrigendum